Brief: EQL Pharma Q2 EBIT SEK 14.3 Million
06/11/2024 06:01
Nov 06 (Reuters) - EQL Pharma Q2 revenue SEK 85.2 million. * Q2 EBIT margin 17% * Q2 adjusted free cash flow SEK 1.4 million
EQL — EQL Pharma AB News Story
0.000.00%
Last trade - 00:00- SEK670.32m
- SEK1.07bn
- SEK432.66m